San Mateo, CA, United States of America

Jeffrey N Hemenway

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 10.7

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Certainly! Here is the article about inventor Jeffrey N Hemenway:

Title: Unveiling the Ingenious Inventor: Jeffrey N Hemenway

Introduction: Meet Jeffrey N Hemenway, a prolific inventor based in the vibrant city of San Mateo, California, with a remarkable track record in the field of pharmaceutical innovations.

Latest Patents: Jeffrey N Hemenway recently secured two groundbreaking patents. The first patent pertains to stable novel salt forms of N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamide, showcasing their utility in the preparation of pharmaceutical formulations. The second patent unveils novel solid forms of FXR agonists, crucial for treating conditions mediated by FXR.

Career Highlights: Having contributed significantly to the industry, Jeffrey has lent his expertise to renowned companies like Gilead Sciences, Inc. and Sierra Oncology, Inc., where he played a pivotal role in driving innovation and advancements in pharmaceuticals.

Collaborations: Along his journey, Jeffrey N Hemenway has collaborated with esteemed professionals such as Ernest A Carra and Bing Shi, fostering a culture of creativity and excellence in the realm of pharmaceutical inventions.

Conclusion: In essence, Jeffrey N Hemenway stands as a beacon of innovation, with his patents and contributions paving the way for transformative developments in the pharmaceutical landscape. His dedication and inventive spirit continue to inspire and shape the future of pharmaceutical research and development.

I hope you find this article about Jeffrey N Hemenway informative and engaging! If you have any more requests or need further information, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…